EUVIMEDEUVIMED entdecken
Crossref

High-throughput protein A chromatography platform for accurate antibody quantification in IV admixtures

Tse-Hong Chen, Xiaoyang Liu, Shao-Chun Wang, Mohammed Shameem, Kenneth S Graham

Analytical Biochemistry · 2026

DOI: 10.1016/j.ab.2025.115982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Biochemistry, 2026. Verfasst von Tse-Hong Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Formulation Development Group, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Rd, Tarrytown, NY, 10591, USA. Electronic address: tsehong.che…. Hauptthemen laut MEDLINE: Staphylococcal Protein A, Chromatography, Affinity, Antibodies, Bispecific, High-Throughput Screening Assays. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibodies hold significant therapeutic potential, but accurate quantification of them in complex intravenous (IV) admixtures is critical for ensuring therapeutic efficacy and patient safety. Traditional reversed-phase liquid chromatography (RPLC) often faces challenges in resolving antibodies from non-product related impurities within IV matrices. This study first evaluates the specificity of Protein A (ProA) affinity chromatography for quantifying bispecific antibodies (BsAbs) in IV matrices. The method leverages the selective binding of ProA to the antibody Fc region to achieve clear separation of antibodies from potential interference, including human serum albumin (HSA), and extractables and leachables (E&L) from contact materials, enabling accurate quantification down to 0.1 μg/mL. The fit-for-purpose method qualification secondly demonstrates linearity, accuracy, and precision across the tested concentration ranges. The ProA method achieves rapid and complete separation in 5 min without sample preparation, significantly enhancing throughput. This platform capability is further demonstrated by its successful application to five different BsAbs in this study. These findings highlight the ProA method as a reliable, efficient, and specific approach for accurately quantifying antibodies in the presence of challenging IV admixture matrices, supporting the development and administration of low-dose antibody therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcal Protein AChromatography, AffinityAntibodies, BispecificHigh-Throughput Screening AssaysHumansSerum Albumin, Human

Stichwörter der Autor:innen

BiotherapeuticsBispecific antibodyIn-use stabilityIntravenous admixturesMatrix interferenceMonoclonal antibodyProtein A chromatographyQuantification

Substanzen

Staphylococcal Protein AAntibodies, BispecificSerum Albumin, Human

Autor:innen und Institutionen

  • Formulation Development Group, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Rd, Tarrytown, NY, 10591, USA. Electronic address: tsehong.chen@regeneron.com.
  • Formulation Development Group, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Rd, Tarrytown, NY, 10591, USA.

Zitieren

APA

Chen, T. H., Liu, X., Wang, S. C., Shameem, M., & Graham, K. S. (2026). High-throughput protein A chromatography platform for accurate antibody quantification in IV admixtures. Analytical Biochemistry. https://doi.org/10.1016/j.ab.2025.115982

Vancouver

Chen TH, Liu X, Wang SC, Shameem M, Graham KS. High-throughput protein A chromatography platform for accurate antibody quantification in IV admixtures. Analytical Biochemistry. 2026. doi:10.1016/j.ab.2025.115982

BibTeX
@article{Chen2026,
  author = {Chen, Tse-Hong and Liu, Xiaoyang and Wang, Shao-Chun and Shameem, Mohammed and Graham, Kenneth S},
  title = {High-throughput protein A chromatography platform for accurate antibody quantification in IV admixtures},
  journal = {Analytical Biochemistry},
  year = {2026},
  doi = {10.1016/j.ab.2025.115982}
}
Kostenlos starten →